LTP Share Price Performance
AU$0.45
-0.76 (-63.22%)
Price AU$0.45
Share PriceAU$0.45
We're Not Worried About LTR Pharma's (ASX:LTP) Cash Burn
Oct 18
LTR Pharma Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
LTP Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
LTR Pharma Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -0.031
- -84.75%
- -370.83%
- 0%
About LTP
- Founded
- 2020
- Employees
- n/a
- CEO
- WebsiteView website
LTR Pharma Limited, a clinical-stage pharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia. Its lead product candidate is SPONTAN, an intranasal delivery technology, an oral PDE5 inhibitor and vardenafil HCL for the treatment of ED. The company was incorporated in 2020 and is headquartered in Brisbane, Australia.
